ST段抬高型心肌梗死院前预通知的预测因素及其与结局的关联
该回顾性研究基于2013—2018年维多利亚心脏结局登记数据,纳入因ST段抬高型心肌梗死接受直接经皮冠状动脉介入治疗的患者,按是否经救护车院前预通知分为三组。预通知组首诊医疗接触至球囊扩张时间短于无预通知组(104分钟 vs 132分钟,p<0.001),但两组30天主要不良心脑血管事件(7.4% vs 9.1%,p=0.05)和死亡率(4.6% vs 5.9%,p=0.07)无显著差异;自行就诊组临床结局更优。男性、右冠状动脉罪犯血管及工作时间就诊独立预测预通知使用(均p<0.05)。作者建议改善院前ST段抬高型心肌梗死诊断的系统不平等以加快治疗。
要点
- 院前预通知组首诊医疗接触至球囊扩张时间104分钟,无预通知组132分钟(p<0.001)。
- 预通知组与无预通知组30天主要不良心脑血管事件7.4% vs 9.1%(p=0.05),死亡率4.6% vs 5.9%(p=0.07),均无显著差异。
- 自行就诊组临床结局优于救护车两组,且心源性休克发生率最低(p<0.001)。
- 男性、右冠状动脉罪犯血管及工作时间就诊独立预测院前预通知使用(均p<0.05)。
- 预通知组更可能在工作时间就诊(p=0.004)。
适用人群与场景
- 2013—2018年因ST段抬高型心肌梗死接受直接经皮冠状动脉介入治疗的患者,数据来自维多利亚心脏结局登记的前瞻性数据。
- 排除心脏骤停后患者。
- 分为三组:经救护车且院前预通知(第1组,n=2891,79.3%男性)、经救护车无预通知(第2组,n=1620,75.7%男性)、自行就诊(第3组,n=1220,82.9%男性)。
研究设计与关键结果
- 研究类型为回顾性研究,基于前瞻性维多利亚心脏结局登记数据,纳入2013—2018年因ST段抬高型心肌梗死接受直接经皮冠状动脉介入治疗的患者,排除心脏骤停后患者。
- 第1组2891例(79.3%男性),第2组1620例(75.7%男性),第3组1220例(82.9%男性)。
- 预通知组更可能在工作时间就诊(p=0.004);自行就诊组心源性休克发生率最低(p<0.001)。
- 首诊医疗接触至球囊扩张时间:预通知组104分钟 vs 无预通知组132分钟(p<0.001)。
- 30天主要不良心脑血管事件:第1组7.4% vs 第2组9.1%(p=0.05);死亡率:第1组4.6% vs 第2组5.9%(p=0.07)。
- 自行就诊组临床结局优于救护车两组,救护车两组间无差异。
- 多因素分析中,男性、右冠状动脉罪犯血管及工作时间就诊独立预测预通知使用(均p<0.05)。
证据类型、等级与局限
- 证据类型:回顾性研究,基于前瞻性登记数据。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者建议改善院前ST段抬高型心肌梗死诊断的系统不平等,以实现最快的ST段抬高型心肌梗死治疗。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Delay to reperfusion in ST-elevation myocardial infarction (STEMI) is detrimental, but can be minimised with prehospital notification by ambulance to the treating hospital. We aimed to assess whether prenotification was associated with improved first medical contact to balloon times (FMC-BT) and whether this resulted in better clinical outcomes. We also aimed to identify factors associated with use of prenotification.
METHODS: This was a retrospective study of prospective Victorian Cardiac Outcomes Registry data for patients undergoing primary percutaneous coronary intervention for STEMI from 2013-2018. Postcardiac arrest were excluded. Patients were grouped by whether they arrived by ambulance with prenotification (group 1), arrived by ambulance without prenotification (group 2) or self-presented (group 3). We compared groups by FMC-BT, incidence of major adverse cardiac and cerebrovascular events (MACCE), mortality and factors associated with the use of prenotification.
RESULTS: 2891 patients were in group 1 (79.3% male), 1620 in group 2 (75.7% male) and 1220 in group 3 (82.9% male). Patients who had prenotification were more likely to present in-hours (p=0.004) and self-presenters had lowest rates of cardiogenic shock (p<0.001). Prenotification had shorter FMC-BT than without prenotification (104 min vs 132 min, p<0.001) Self-presenters had superior clinical outcomes, with no difference between ambulance groups. Groups 1 and 2 had similar 30-day MACCE outcomes (7.4% group 1 vs 9.1% group 2, p=0.05) and similar mortality (4.6% group 1 vs 5.9% group 2, p=0.07). In multivariable analysis, male gender, right coronary artery culprit and in-hours presentation independently predicted use of prenotification (all p<0.05).
CONCLUSION: Differences in clinical characteristics, particularly gender, time of presentation and culprit vessel may influence ambulance prenotification. Ambulance cohorts have high-risk features and worse outcomes compared with self-presenters. Improving system inequality in prehospital STEMI diagnosis is recommended for fastest STEMI treatment.
参考来源
- Blusztein D, Dinh D, Stub D, et al. Predictors of hospital prenotification for STEMI and association of prenotification with outcomes. Emerg Med J. 2021. PMID: 34907005. doi:10.1136/emermed-2020-210522
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。